GRI — GRI BIO INC
As of Q2 2026, 5 SEC-registered investment managers reported holding GRI (GRI BIO INC) in their latest 13F filings, with a combined reported value of $72.41K across 40.91K shares. That is +50.6% by share count (+13.74K shares) versus the previous quarter, while reported value moved +16.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
GRI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Geode Capital Management history | Q2 2026 | 13.87K | $24.55K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 13.38K | $23.68K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 8.74K | $15.46K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 4.92K | $8.71K | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 17.00K | $4.20K | 0.00% | Hold |
| Renaissance Technologies history | Q4 2023 | 40.00K | $15 | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 7 | $12 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 23 | $5 | 0.00% | Add |
| Wells Fargo & Co history | Q1 2024 | 4 | $3 | 0.00% | Reduce |
New Positions (Q2 2026)
- Citadel Advisors 13.38K sh · $23.68K
- Morgan Stanley 8.74K sh · $15.46K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 9 funds)
| Fund | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 14.88K | 14.87K | 14.75K | — | — | 11.85K | 76.18K | — | — | 12.37K | 23.18K | 18.44K | 13.87K |
| Citadel Advisors | — | — | 86.12K | — | — | — | — | — | — | — | — | — | 13.38K |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | — | — | — | 8.74K |
| UBS Group AG | 899 | — | 2.39K | 8.02K | 17.96K | 71.65K | 92.27K | 3.25K | 15.46K | 27 | — | 8.72K | 4.92K |
| BlackRock Inc | — | — | — | — | — | 3.60K | 3.60K | 211 | 211 | 211 | 211 | 7 | 7 |
| Bank of America Corp | — | — | — | — | 2 | 23 | 73 | 4 | 19 | 22 | 23 | — | — |
| Vanguard Group | — | 18.54K | 18.54K | — | — | — | — | — | — | 17.00K | 17.00K | — | — |
| Renaissance Technologies | — | — | 40.00K | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 20 | 14 | 15 | 4 | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details